Nevirapine (Breckenridge Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Nevirapine drug offered from Breckenridge Pharmaceutical, Inc.. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Breckenridge Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | NEVIRAPINE |
| SUBSTANCE NAME: | NEVIRAPINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-04-11 |
| END MARKETING DATE: | 0000-00-00 |
Nevirapine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nevirapine from Breckenridge Pharmaceutical, Inc. |
| LABELER NAME: | Breckenridge Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2011-04-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51991-331_996b0adc-01de-4c25-995e-ba95ce8059d4 |
| PRODUCT NDC: | 51991-331 |
| APPLICATION NUMBER: | ANDA078644 |
Other NEVIRAPINE Pharmaceutical Manufacturers / Labelers:
